Crohn's Disease and Colitis Trial, Recruiting (NCT07591012)

Crohn's Disease and Colitis Trial, Recruiting NCT07591012 Sponsor: University of Padova Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT07591012 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with ulcerative colitis (a condition causing inflammation in the large intestine), confirmed through medical examination, a camera examination of the bowel, and tissue testing
People whose ulcerative colitis is currently in remission (not flaring up), also confirmed through medical examination, bowel camera examination, and tissue testing
People aged between 18 and 75 years old
People who are able to take part fully in all parts of the trial

Who may not be able to join:

People whose ulcerative colitis is currently active (meaning they are currently having a flare-up), as confirmed by medical, bowel camera, and tissue examination
People who have been diagnosed with Crohn's disease, indeterminate colitis, ischemic colitis, radiation colitis, colitis related to diverticular disease, or microscopic colitis
People whose stool test has come back positive for an active C. difficile infection (a type of bacterial gut infection)
People who are pregnant
People who have taken antibiotics or probiotic supplements within the 10 days before their first trial visit

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Edoardo V Savarino, Università degli Studi di Padova, DiSCOG

Phone: 00390498127749

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07591012

Sponsor: University of Padova

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 00390498127749

More information: https://clinicaltrials.gov/study/NCT07591012

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with ulcerative colitis (a condition causing inflammation in the large intestine), confirmed through medical examination, a camera examination of the bowel, and tissue testing
People whose ulcerative colitis is currently in remission (not flaring up), also confirmed through medical examination, bowel camera examination, and tissue testing
People aged between 18 and 75 years old
People who are able to take part fully in all parts of the trial

Who may not be able to join:

People whose ulcerative colitis is currently active (meaning they are currently having a flare-up), as confirmed by medical, bowel camera, and tissue examination
People who have been diagnosed with Crohn's disease, indeterminate colitis, ischemic colitis, radiation colitis, colitis related to diverticular disease, or microscopic colitis
People whose stool test has come back positive for an active C. difficile infection (a type of bacterial gut infection)
People who are pregnant
People who have taken antibiotics or probiotic supplements within the 10 days before their first trial visit

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Padova

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Assessment of the clinical effectiveness of ButyMixx

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov